Results 81 to 90 of about 27,170 (181)

Liver transplantation and primary liver cancer in porphyria

open access: yesLiver International, Volume 45, Issue 3, March 2025.
Abstract The porphyrias are a heterogeneous group of metabolic disorders that result from defects in heme synthesis. The metabolic defects are present in all cells, but symptoms are mainly cutaneous or related to neuropathy. The porphyrias are highly relevant to hepatologists since patients can present with symptoms and complications that require liver
Mattias Lissing   +2 more
wiley   +1 more source

Practical recommendations for biochemical and genetic diagnosis of the porphyrias

open access: yesLiver International, Volume 45, Issue 3, March 2025.
Abstract The porphyrias are a group of rare inborn errors of metabolism associated with various clinical presentations and long‐term complications, making them relevant differential diagnoses to consider for many clinical specialities, especially hepatologists, gastroenterologists and dermatologists.
Aasne K. Aarsand   +4 more
wiley   +1 more source

Downregulation of intestinal Farnesoid X Receptor in Erythropoietic protoporphyria [PDF]

open access: yes, 2017
Erythropoietic protoporphyria (EPP) is characterized by accumulation of protoporphyrin IX (PPIX) in the body. The liver is the major organ responsible for PPIX excretion through the biliary system. Because PPIX is highly hydrophobic, an excess amount of
Pradhan, Komal
core  

Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families

open access: yes, 1990
Erythropoietic protoporphyria (EPP) is associated with a deficiency of protohaem ferrolyase. We have used a novel assay for this enzyme based on its ability to utilize zinc as a substrate to investigate the inheritance of EPP in nine affected families ...
Cox, T M   +3 more
core   +1 more source

Erythropoietic protoporphyria patients in Slovenia

open access: yes, 2015
Background: There are only scarce epidemiological data on the prevalence of erythropoietic protoporphyria (EPP) in a given population. The aim of this study was to assess the prevalence of EPP within the Slovenian population.
Marko, Pij B.   +4 more
core  

The role of ClpX in erythropoietic protoporphyria

open access: yes, 2018
Hemoglobin is an essential biological component of human physiology and its production in red blood cells relies upon proper biosynthesis of heme and globin protein.
Jacky Chung   +5 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +2 more sources

Exacerbation of erythropoietic protoporphyria by hyperthyroidism [PDF]

open access: yes, 2018
Erythropoietic protoporphyria (EPP) is a hereditary disorder caused by deficiency of ferrochelatase, the last enzyme in the heme biosynthetic pathway. The majority of EPP patients present with a clinical symptom of painful phototoxicity.
Minder, Elisabeth   +2 more
core  

Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease

open access: yes, 2018
The porphyrias are a group of rare metabolic disorders that result from defects in heme biosynthesis. Erythropoietic protoporphyria (EPP) is the most common inherited porphyria in children and is diagnosed in most individuals after the onset of cutaneous
Daniel H. Leung   +2 more
core   +1 more source

Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria

open access: yes, 2007
Erythropoietic protoporphyria (EPP) results from deficiency of ferrochelatase (FECH). Accumulation of protoporphyrin IX causes life-long acute photosensitivity. Microcytic anemia occurs in 20% to 60% of patients.
Badminton, Michael Norman   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy